Prevalence of Alcohol and Tobacco Use in India and Implications for COVID-19 - Niyantrita Madhumeha Bharata Study Projections

Author:

Sai Sivapuram Madhava, ,Nagarathna Raghuram,Anand Akshay,Patil Suchitra,Singh Amit,Ramarao Nagendra Hongasandra, , , , , , ,

Abstract

Abuse of legal substances in India includes alcohol and tobacco, which are the major risk factors for various non-communicable diseases and deaths. The current pandemic has identified tobacco consumption as a risk factor for COVID-19, highlighting the need to control substance abuse. The objective of this study was to estimate the prevalence of substance abuse in India and discuss the cost-effective public health strategies (such as yoga) to alleviate COVID-related anxiety in order to prevent substance abuse and its associated co-morbidities such as type 2 diabetes mellitus. This study reports the data on tobacco and alcohol abuse from a nationwide randomized two-arm diabetes control trial (Niyantrita Madhumeha Bharata, 2017) conducted by the Indian Yoga Association (IYA) through Swami Vivekananda Yoga Anusandhana Samsthana (S-VYASA), Bengaluru. Data of 30,354 participants who abuse tobacco and 30,159 participants who abuse alcohol were collected all over India. The prevalence is estimated at around 8.7% for alcohol abuse and 7.9% for tobacco abuse, Arunachal Pradesh state ranking the highest regarding both alcohol and tobacco abuse, while the Tripura state ranked the lowest. School and college-based mandatory yoga programs need to be implemented to prevent the increase of substance abuse in India to alleviate the psychosocial stress of adolescents and college-going students, besides the installation of the mindfulness-based diabetes yoga protocol (DYP) in the wellness centers of Ayushman Bharat.

Publisher

S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L

Subject

General Medicine

Reference48 articles.

1. 1. Atzendorf J, Rauschert C, Seitz NN, Lochbühler K, Kraus L. The Use of Alcohol, Tobacco, Illegal Drugs and Medicines. Dtsch Arztebl Int. 2019;116(35-36):577-584.

2. 2. Stockings E, Hall WD, Lynskey M, Morley KI, Reavley N, Strang J, Patton G, Degenhardt L. Prevention, early intervention, harm reduction, and treatment of substance use in young people. Lancet Psychiatry. 2016;3(3):280-96.

3. 3. José BPS, Corrêa RA, Malta DC, Passos VMA, França EB, Teixeira RA, Camargos PAM. Mortality and disability from tobacco- related diseases in Brazil, 1990 to 2015. Rev Bras Epidemiol. 2017;20(Suppl 01):75-89.

4. 4. World Health Organization (WHO). WHO factsheet on tobacco use. Geneva: World Health Organization;2018. [cited 2020Apr23]. Available from: https://apps.who.int/iris/bitstream/handle/10665/272672/wntd_2018_india_fs.pdf?sequence=1

5. 5. World Health Organization (WHO). WHO report on the global tobacco epidemic, 2013. Enforcing bans on tobacco advertising, promotion and sponsorship. Geneva: World Health Organization; 2013. [cited 2020Apr23]. Available from: http://apps.who.int/iris/ bitstream/10665/85380/1/9789241505871_eng. pdf ?ua=1

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3